Michael Klichinsky - 28 Jan 2025 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Chief Scientific Officer
Signature
/s/ Steven Kelly, as Attorney-in-Fact for Michael Klichinsky
Issuer symbol
CARM
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4
Filing time
30 Jan 2025, 16:02:15 UTC
Previous filing
18 Jun 2024
Next filing
03 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +221,000 $0.000000 221,000 28 Jan 2025 Common Stock 221,000 $0.5000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.